Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

20. August 2021 - 0:00 (CEST)

Epigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share

Read more

17. August 2021 - 0:00 (CEST)

Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

Read more

11. June 2021 - 0:00 (CEST)

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million

Read more

Press releases

13. September 2021

Epigenomics AG places maximum number of mandatory convertible bonds with a total volume of EUR 16.5 million

Read more

02. September 2021

New study in the BMC Cancer journal shows that Epi proColon(R) is an effective method to increase CRC screening rates in medically underserved populations

Read more

24. August 2021

Epigenomics AG: Securities prospectus for the issuance of a mandatory convertible bond in the amount of up to EUR 16.5 million approved by BaFin

Read more